Lv41
510 积分 2023-04-19 加入
Anti-CD19/CD8 bispecific T cell engager for the potential treatment of B cell malignancies
2小时前
已完结
TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers
8天前
已完结
Preferentially Expressed Antigen of Melanoma (PRAME) in the Development of Diagnostic and Therapeutic Methods for Hematological Malignancies
2个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
2个月前
已完结
New immune cell engagers for cancer immunotherapy
2个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
2个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
3个月前
已完结
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
3个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
3个月前
已完结
T cell-engaging therapies — BiTEs and beyond
3个月前
已完结
皖公网安备34019202002308
